| Title： | Guidelines for Primary Prevention of Osteoporosis Fractures in China |
| Edition： | Original |
| Classification： | Standard guideline |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | Clinicians, clinical pharmacists, and registered nurses from all medical institutions who receive patients with osteopenia, osteoporosis, and osteoporotic fractures. |
| Evidence classification method： | Quality level Definition High We are very confident that the true effect lies close to that of the estimate of the effect. Moderate We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. Low Our confidence in the effect estimate is limited: the true effect may be substantially different from theestimate of the effect. Very low We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. |
| Development unit： | Osteoporosis Prevention and Rehabilitation Professional Committee of the Chinese Association of Rehabilitation Medicine |
| Registration time: | 2024-04-23 |
| Registration number： | PREPARE-2024CN579 |
| Purpose of the guideline: | To improve and optimize the primary prevention strategy for osteoporotic fractures, enhance the health management level of health care provider for high-risk populations of fragility fractures, and enhance the self-protection awareness of high-risk populations. |
Latest registration
